Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
126,235,733
-
Total 13F shares
-
125,970
-
Share change
-
+114,469
-
Total reported value
-
$87,462
-
Price per share
-
$0.69
-
Number of holders
-
12
-
Value change
-
+$79,538
-
Number of buys
-
8
Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) as of Q3 2024
As of 30 Sep 2024,
NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
125,970 shares.
The largest 10 holders included
C2C Wealth Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Virtu Financial LLC, Warberg Asset Management LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, BANK OF AMERICA CORP /DE/, NVWM, LLC, and Blue Trust, Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.